triphenylacetic acid has been researched along with Anemia, Sickle Cell in 1 studies
*Anemia, Sickle Cell: A disease characterized by chronic hemolytic anemia, episodic painful crises, and pathologic involvement of many organs. It is the clinical expression of homozygosity for hemoglobin S. [MeSH]
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arrington, S; Burns, JF; Creech, C; de Franceschi, L; McNaughton-Smith, GA; Rigdon, GC; Shelton, T; Stocker, JW | 1 |
1 other study(ies) available for triphenylacetic acid and Anemia, Sickle Cell
Article | Year |
---|---|
Novel inhibitors of the Gardos channel for the treatment of sickle cell disease.
Topics: Acetamides; Anemia, Sickle Cell; Animals; Biological Availability; Clotrimazole; Humans; Intermediate-Conductance Calcium-Activated Potassium Channels; Male; Mice; Potassium Channel Blockers; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Trityl Compounds | 2008 |